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Characterization of reduced and alkylated rat selenoprotein P by mass spectrometry yielded
selenopeptides from which one or more selenium atoms were missing. Predicted selenopep-
tide mass peaks were accompanied by peaks corresponding to the conversion of one or more
selenocysteine residues to dehydroalanine(s). Experiments were carried out to determine
whether this loss of selenium occurred in vitro. A selenopeptide was isolated that contained
two selenocysteine residues that were both in selenide-sulfide linkages with cysteine residues.
After the peptide had been reduced and alkylated, in addition to the predicted mass peak with
both selenocysteine residues present, two mass peaks were detected at positions expected for
conversion of one and two selenocysteine residues of this selenopeptide to dehydroalanine
residues, which was confirmed by tandem mass spectrometry. Similar findings were obtained
from a study of another selenoprotein, rat plasma glutathione peroxidase. These results
indicate that selenium atoms are lost from selenoproteins during purification and character-
ization. The loss of selenium from selenoproteins is probably through the mechanism of
oxidation of selenocysteine residue to selenoxide followed by syn--elimination of selenenic
acid during sample processing. (J Am Soc Mass Spectrom 2003, 14, 593–600) © 2003
American Society for Mass Spectrometry
Selenoprotein P is a heparin-binding protein [1]that circulates in the plasma as several isoforms[2]. The full-length isoform contains ten selenocys-
teine residues in its primary structure. During charac-
terization studies of this isoform using mass spectro-
metry, we observed selenopeptides that had lost some
of their selenium atoms. This observation raised the
possibilities (1) that tissues can remove selenium atoms
from circulating selenoprotein P, possibly as part of a
selenium transport mechanism [3, 4], and/or (2) that
selenium is lost as a consequence of the isolation
procedure.
We carried out several experiments to characterize
this removal of selenium from selenoprotein P and to
assess its occurrence in plasma glutathione peroxidase.
Those experiments indicated that loss of selenium at-
oms occurs in vitro and is not a result of a selenium
transport function of the protein.
Experimental
Materials
Matrix, -cyano-4-hydroxycinnamic acid (CHCA), was
purchased from Aldrich Chemical Co. (Milwaukee,
WI). Ammonium bicarbonate, iodoacetamide, dithio-
threitol (DTT), and peptide standards used for mass
calibration, des-Arg1-bradykinin and bovine insulin,
were purchased from Sigma Chemical Co. (St. Louis,
MO). N-tosyl-L-phenylalanylchloromethyl ketone
(TPCK)-treated porcine trypsin was obtained from Pro-
mega (Madison, WI). Endoproteinase Glu-C was ob-
tained from Boehringer Mannheim (Indianapolis, IN).
The deglycosylation kit, which contained N-glycosidase
F (PNGase F), endo-O-glycosidase, and Sialidase A, was
purchased from ProZyme (San Leandro, CA).
Selenoprotein P and Glutathione Peroxidase
Purification
Selenoprotein P was purified and its full-length isoform
was separated as described previously [2, 5]. Glutathi-
one peroxidase was purified from rat plasma that had
been depleted of selenoprotein P by passage over an
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immunoaffinity column [5]. The pellet from a 30 to 50%
ammonium sulfate precipitation was dissolved in
buffer A (50 mM Tris-HCl pH 8.5, 5 mM EDTA, 1 mM
GSH) and dialyzed overnight against buffer A. It was
then applied to a DEAE cellulose column and eluted
with a linear NaCl gradient from 0 to 0.3 M in buffer B
(200 mM Tris-HCl pH 8.5, 5 mM EDTA, 1 mM GSH).
Fractions containing glutathione peroxidase activity
were combined and concentrated and passed over a
Sephacryl 300 column in buffer A. Fractions containing
glutathione peroxidase activity were combined, concen-
trated, and buffer exchanged to buffer C (0.1 M Tris-
HCl pH 7.2, 0.2 M ammonium sulfate, 5 mM EDTA, 1
mM GSH). The sample was then applied to a 5 ml
HiTrap phenyl sepharose column from Pharmacia (Pis-
cataway, NJ) equilibrated with buffer C. The glutathi-
one peroxidase activity was eluted with a linear gradi-
ent composed of equal volumes of buffer C and buffer
D (0.08 M Tris-HCl pH 7.2, 0.16 M ammonium sulfate,
5 mM EDTA, 1 mM GSH). Fractions containing gluta-
thione peroxidase activity were combined, concen-
trated, and applied to a HiTrap Blue column (Pharma-
cia, Piscataway, NJ) equilibrated with buffer D.
Glutathione peroxidase was not retained by this column
and appeared in the flow through fractions.
Selenoprotein P Deglycosylation and Enzymatic
Digestion of Selenoprotein P and Glutathione
Peroxidase
Deglycosylation of the selenoprotein P full-length iso-
form was accomplished using N-glycosidase F, endo-O-
glycosidase, and sialidase A [2]. Trypsin digestion of
the deglycosylated and unmodified selenoprotein P
(approximately 10 g) was carried out as previously
described [2]. Purified glutathione peroxidase (approx-
imately 10 g) was digested using Glu-C according to
the protocol used for selenoprotein P [2].
Reverse Phase High Performance Liquid
Chromatography (HPLC)
Digestion mixtures were separated on a Vydac micro-
bore C18 column (2.1 250 mm) (Vydac, Hesperia, CA)
using an HP 1100 HPLC system (Hewlett-Packard Co.,
Wilmington, DE). The mobile phase consisted of (1)
0.1% trifluoroacetic acid in H2O and (2) 94.9% acetoni-
trile, 5% H2O, and 0.1% trifluoroacetic acid. The com-
bined flow was maintained at 0.2 ml/min. The separa-
tion was monitored with a UV detector at 214 nm. The
gradient elution conditions were the same as used
before [2]. UV monitored peptide peaks were manually
collected in microcentrifuge tubes. The HPLC fractions
were lyophilized dry and reconstituted in 40 L of 50%
acetonitrile/50% H2O/0.1% trifluoroacetic acid for
mass spectrometry analysis.
Mass Spectrometry
Matrix-assisted laser desorption ionization (MALDI)
mass spectra were acquired using a Voyager DE-STR
MALDI-TOF mass spectrometer (Applied Biosystems,
Foster City, CA). The samples were prepared on a
stainless steel plate by the dried-droplet method using
CHCA as matrix. CHCA was dissolved in 50:49.9:0.1 of
water:acetonitrile:trifluoroacetic acid at a concentration
of 10 mg/ml. Mass calibration was accomplished using
des-Arg1-bradykinin (MW 903.46) and bovine insulin
(MW 5733.58).
Nanoelectrospray MS/MS was performed on a
QSTAR quadrupole time-of-flight (Q-TOF) mass spec-
trometer (PE Sciex, Concord, Ontario, Canada)
equipped with a nanoelectrospray ion source (Protana
A/S, Odense, Denmark). The peptide sample (approx-
imately 5 pmol/L) of 2 L was loaded into the
metal-coated glass capillary (Protana A/S, Odense,
Denmark). A stable spray was obtained at spray voltage
of 800-900 Volts. Positive ion mass spectra were ac-
quired in the profile mode with an ion count accumu-
lation time of 1 sec at a TOF pulse frequency of 6.99
kHz. Peptide sequences were obtained from product
ion spectra acquired for ions selected with Q1 and
dissociated with collision energy of 30 to 45 eV. The
collision gas was set at 6 (arbitrary units).
Results
Selenopeptide Shows Loss of Selenium
During the characterization of full-length selenoprotein
P by mass spectrometry, peptides containing one to
four selenocysteine residues were generated by proteo-
lytic digestion [2]. Figure 1 shows the MALDI-TOF
mass spectrum of such a tryptic peptide (SPPAAU-
HSQHVSPTEASPNUSUNNK, residues 333–357, U 
selenocysteine) that contains three selenocysteine resi-
dues. The signal at m/z 2880.0 corresponds to the
expected selenopeptide with all the three selenocysteine
residues alkylated by iodoacetamide. Besides this ex-
pected peptide ion signal, additional ion signals at m/z
2742.5 and 2604.7 are observed. It is significant to note
that all three ions have selenium isotope patterns when
studied under reflector MALDI-TOF conditions (data
not shown). The ion at m/z 2880.0 has an isotope pattern
characteristic of three selenium atoms, while the ion at
m/z 2742.5 has a pattern characteristic of two selenium
atoms and the ion at m/z 2604.7 has a pattern character-
istic of one selenium atom (see on-line supplement of
reference 2 for appearance of these patterns). These
results imply that the ions at m/z 2742.5 and 2604.7
correspond to peptides arising from sequential loss of
selenium atoms from the expected selenopeptide. The
ion at m/z 2742.5 corresponds to the peptide with
conversion of one selenocysteine to dehydroalanine,
while the ions at m/z 2604.7 corresponds to the peptide
with conversion of two selenocysteines to dehydroala-
594 MA ET AL. J Am Soc Mass Spectrom 2003, 14, 593–600
nines. As the number of selenium atoms lost increases,
the corresponding ion signal drops sharply. We did not
observe the peptide corresponding to the conversion of
all three selenocysteine residues to dehydroalanine.
Conversion of selenocysteine to dehydroalanine (mass
loss of 81) together with the loss of acetamide adduct
(mass of 57, dehydroalanine cannot be alkylated by
iodoacetamide), would count for the mass loss of 138.
This is consistent with the additional ions appearing at
intervals of 138 Da below the expected selenopeptide
ion.
Selenium Lost in Vitro
The results of Figure 1 are consistent with in vivo or in
vitro removal of selenium atoms from selenoprotein P.
An experiment was carried out to determine whether
removal of selenium atoms occurs during analysis of
the protein. To assess removal in vitro, we isolated a
tryptic peptide from full-length isoform that had been
neither reduced nor alkylated before digestion. This
peptide consists of amino acid residues 298–324 (SG-
SAITUQCAENLPSLCSUQGLFAEEK) and contains two
selenocysteine residues. This peptide has been shown to
contain two selenide™sulfide (Se™S) bonds from se-
cys304 to cys314 and from cys306 to secys316 (Ma, S.;
Hill, K. E.; Burk, R. F.; Caprioli, R. M., manuscript in
preparation). As shown in Figure 2a, the ion at m/z
2881.4 corresponds to this double Se™S linked peptide.
There are no ion signals that correspond to the conver-
sion of selenocysteine residues to dehydroalanine. This
suggests that selenocysteine residues involved in se-
lenide-sulfide linkages are not susceptible to loss of the
selenium atom.
This peptide was then reduced by DTT and alkylated
by iodoacetamide. The mass spectrum in Figure 2b
contains an ion at m/z 3113.0, corresponding to the
peptide with its two selenocysteine residues and two
cysteine residues reduced and alkylated by iodoacet-
amide. The ion at m/z 2997.0 most likely resulted from
the peptide with one selenide™sulfide bond being re-
duced and alkylated while the other selenide™sulfide
bond remained intact. The ion at m/z 3055.6 corresponds
to the peptide with both selenide-sulfide bonds re-
duced, but with one selenocysteine or cysteine residue
remaining free. Under these conditions, additional ions
at m/z 2975.6 and 2837.0 are observed. Those ions
correspond to the conversion of one and two selenocys-
teine residues to dehydroalanine. This result indicates
that the loss of selenium can occur in vitro.
The sequences of the peptides arising from conver-
sion of one and two selenocysteine residues to dehy-
droalanine(s) were confirmed by nanoelectrospray ion-
ization MS/MS. Since peptide 298–324 contains
selenocysteine residues at positions 304 and 316, con-
version of either of these residues to dehydroalanine
would yield a peptide with loss of 1 selenium atom.
Therefore, the ion at m/z 2975.6 should represent two
peptides. The tandem mass spectrum was obtained
from the fragmentation of these two isobaric peptides
as shown in Figure 3a. The y- and b-ion series were
used to label the fragments from the peptide with
conversion of the selenocysteine residue at position 304
to dehydroalanine, while Y- and B-ion series were used
for the fragments from the peptide with conversion of
the selenocysteine residue at position 316 to dehy-
droalanine. Since the only differences between these
two peptides would be for residues 304 and 316 to be
Figure 1. MALDI-TOF mass spectrum of the tryptic peptide from selenoprotein P, 333SPPAAU-
HSQHVSPTEASPNUSUNNK357. The protein was reduced by DTT, alkylated by iodoacetamide, and
deglycosylated with N-glycosidase F (PNGase F), endo-O-glycosidase, and sialidase A before it was
digested with trypsin.
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either selenocysteine or dehydroalanine, the fragments
of these two peptides should only be different at y9
 to
y20
 and at b7
 to b18
 with a difference of 138 Da between
the bn
 and Bn
 (n  7–18) or ym
 and Ym
 (m  9–20) ion
series. For example, y14
 arising from the cleavage at the
N-terminus of proline 311 is 138 Da greater than Y14
 ion,
while its corresponding b13
 ion is 138 Da lower than B13

(Figure 3a). Figure 3b shows the MS/MS spectrum of
the peptide after loss of both selenium atoms. These
fragmentation patterns (Figure 3a and b) confirm that
the only differences among the peptides at m/z 3113.0,
2975.6, and 2837.0 are for residues 304 and 316 to be
either selenocysteine or dehydroalanine.
Selenium Lost from Glutathione Peroxidase
Loss of selenium atoms from selenoprotein P in vitro
allows the prediction that loss might also occur from
other selenoproteins. We studied glutathione peroxi-
dase, which had been purified from rat plasma. This
selenoprotein is a homotetramer that contains a seleno-
cysteine at residue 54 of each subunit [6].
The protein was reduced, alkylated, and digested
using Glu-C. The peptide mixture was then separated
by C18 reverse phase HPLC. Figure 4 shows the MALDI
mass spectrum of one of the HPLC fractions that
contains major ions at m/z 2836.5 and 2505.3. These
mass peaks correspond to peptides LGPFGLVILGFPC-
NQFGKQEPGENSE (residues 70–95), and LGPFGLV
ILGFPCNQFGKQEPGE (residues 70–92). The insert
spectrum shows the broad up range from m/z 3300 to
3580. The ion at m/z 3513.2 corresponds to the selenopep-
tide, YIPFKQYAGKYILFVNVASYUGLTDQYLE (resi-
dues 34–62). The ion at m/z 3374.9 corresponds to the
mass of the same peptide with the selenocysteine at
residue 54 converted to dehydroalanine. The MS/MS
spectrum shown in Figure 5a confirms the selenopep-
tide sequence, while the MS/MS spectrum in Figure 5b
confirms the peptide sequence after the conversion of
selenocysteine to dehydroalanine at residue 54. The
results of this experiment clearly indicate that the
phenomenon of selenium atom loss is not restricted to
selenoprotein P.
Discussion
Several studies have indicated that selenoprotein P
serves to transport or distribute selenium to various
tissues [3]. Therefore, the mechanism by which the
element is removed from the protein for uptake and
utilization by cells would be an important part of its
transport mechanism. During the course of mass spec-
trometry characterization studies [2], we observed pep-
tides that had selenium atoms missing (Figure 1). We
considered that removal of these selenium atoms might
be part of the selenium transport mechanism. To assess
this possibility, we carried out detailed experiments
using the purified protein.
These mass spectrometry experiments demonstrate
that selenium atoms are removed from selenopeptides
Figure 2. (a) MALDI-TOF mass spectrum of the tryptic peptide from unmodified selenoprotein P,
298SGSAITUQCAENLPSLCSUQGLFAEEK324, which contains two selenide-sulfide (Se™S) linkages of
secys304 to cys314 and cys306 to secys316. (b) MALDI-TOF mass spectrum of the same peptide after
reduction with DTT and alkylation with iodoacetamide.
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in vitro. They further demonstrate that this removal is
not caused by in-source fragmentation during the
MALDI process because the peptides resulting from
loss of selenium were also observed when electrospray
ionization was employed. Also, MS/MS experiments of
the selenopeptide did not show a fragment ion corre-
sponding to loss of selenium. Thus, the loss of selenium
appears to occur during the purification and/or modi-
Figure 3. MS/MS spectra of the peptide (residues 298–324) (a) after conversion of one selenocysteine
(either residue 304 or 316) to dehydroalanine and (b) after conversion of both selenocysteine residues
at 304 and 316 to dehydroalanine residues.
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fication of the protein. Analyses of purified selenopro-
teins for selenium content have sometimes yielded
results that were lower than expected [7]. Such results
might reflect selenium losses during preparation of the
proteins for analysis.
There is precedent for conversion of selenocysteine
to alanine. Twenty years ago, an enzyme was described
in rat liver that converted free selenocysteine to alanine
and elemental selenium [8]. This enzyme, selenocys-
teine -lyase, has been studied further and shown to be
present in the cytosolic fraction of mouse tissues—
principally in liver, kidney, and testis [9]. Those are
tissues that synthesize selenoproteins very actively and
selenocysteine -lyase apparently supplies selenium in
them for this process.
It seems unlikely that selenocysteine -lyase could be
involved in the removal of selenium from selenoprotein
P. The enzyme is intracellular and selenoprotein P is
extracellular. The enzyme utilizes free selenocysteine as
a substrate and selenoprotein P has the amino acid in its
primary structure. Thus, we conclude that this known
biological mechanism for catabolism of selenocysteine
would not remove selenium atoms from selenoprotein
P.
There is renewed interest in -elimination reactions
in seleno-amino acids because of their potential to
generate alkyl selenols that might have cancer chemo-
preventive properties [10, 11]. While studies on this
have focused on intracellular processes, it is theoreti-
cally possible that extracellular -elimination of sele-
nium atoms might occur and release selenium from
extracellular selenoproteins. This possibility needs to be
further investigated.
The findings of this study lead to the conclusion that
loss of selenium atoms from selenoprotein P occurs in
vitro. Loss of selenium also occurs for glutathione
peroxidase from rat plasma, mammalian thioredoxin
reductase [12], and glutathione peroxidase from
chlamydomonas reinhardtii [13]. Therefore, loss of se-
lenium needs to be considered a possibility in studies of
all selenoproteins.
The mechanism of losing selenium from selenopro-
teins is most likely through oxidation of selenocysteine
to selenoxide followed by syn--elimination of sele-
nenic acid initiated by intramolecular abstraction of the
-proton during sample processing. This mechanism is
commonly used to generate unsaturated compounds in
synthetic organic chemistry [14], and most recently, has
been applied to synthesis of dehydroalanine residues
within peptides [15, 16]. A similar mechanism was also
proposed as a bio-activation pathway for pyruvate
formation from the selenocysteine Se-conjugates in rat
liver microsomes. Oxidation of selenocysteine Se-conju-
gates by flavin-containing monooxygenases resulted in
spontaneous -elimination of selenenic acid, leading to
the formation of pyruvate and ammonia [17].
Amino acid residues containing thioethers are easily
oxidized during protein purification, derivatization,
and/or digestion. For instance, oxidation of methionine
residues in proteins during SDS-PAGE was commonly
observed due to residual persulfate in polyacrylamide
[18]. Chemical oxidation of methionine was also found
to occur during capillary zone electrophoresis with
electrospray mass spectrometry analysis as a result of
the electrolysis of water during electrophoresis and at
the electrospray interface [19, 20]. Alkylated cysteine
residues were also found in their oxidized form during
or subsequent to protein digestion [21].
Figure 4. MALDI-TOF mass spectrum of the HPLC separated peptide from Glu-C digestion of
glutathione peroxidase, which shows ion signals at 2505.3 (residues 70–92), 2836.5 (residues 70–95),
and 3513.2 (residues 34–62). The ion at m/z 3374.9 corresponds to the peptide of residues 34–62 after
the conversion of selenocysteine 54 to dehydroalanine.
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Selenoethers are generally much more prone to oxi-
dation to the corresponding selenoxides than are
thioethers to the corresponding sulfoxides. The obser-
vation that selenoxides from selenocysteine residues
undergo syn--elimination of selenenic acid more easily
than cysteine/methionine-derived sulfoxides can be
explained from the weaker bond strength of the C™Se
bond (234 kJ/mol) versus the C™S bond (272 kJ/mol)
[22] and/or a more facile -proton abstraction of the
selenocysteine moiety [23].
Figure 5. Tandem mass spectra of the selenopeptide (residues 34–62) of glutathione peroxidase
shown in Figure 4. (a) MS/MS spectrum of the peptide containing selenocysteine obtained from the
fragmentation of the triply charged ion at m/z 1169.88. (b) MS/MS spectrum of the same peptide after
conversion of selenocysteine to dehydroalanine obtained from the fragmentation of the triply charged
ion at m/z 1124.89.
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Conclusion
The loss of selenium from rat selenoprotein P and
glutathione peroxidase resulted from the conversion of
selenocysteine residues to dehydroalanine residues and
was found to occur during protein purification, deriva-
tization, and/or digestion. The mechanism of selenium
loss from selenoproteins is probably the oxidation of
selenocysteine to selenoxide followed by syn--elimina-
tion of selenenic acid, resulting in the formation of a
dehydroalanine residue in the protein/peptide se-
quence. This phenomenon needs to be considered to be
a possibility in studies of all selenoproteins.
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